Conjugated Estrogens/Bazedoxifene Acetate

结合雌激素/醋酸巴多昔芬

Report date: 2023/03/17 17:33:59

Base Information

Drug NameConjugated Estrogens/Bazedoxifene Acetate
Drug Alias Name醋酸巴多昔芬/结合雌激素Oestrogens conjugated/bazedoxifene acetateBazedoxifene/CEBazedoxifene/PremarinConjugated estrogens/bazedoxifene acetate +[14] 
ClassificationSmall molecules
Mechanisms of ActionEstrogen receptor beta agonistsEstrogen receptor alpha agonists
TargetsEstrogen receptor alphaEstrogen receptor beta
Therapy Area/IndicationsOestrogen deficiency symptomsVasomotor symptomMenopausal symptoms +[14] 
Global Approved IndicationsOestrogen deficiency symptomsVasomotor symptomOsteoporosis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2013/10/03
Country/TerritoryCanadaUnited StatesEU
CombinationsYes Bazedoxifene AcetateConjugated Estrogens
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesWyeth Pharmaceuticals IncPfizer IncPfizer Europe Ma Eeig +[4] 
Inactive CompaniesWyeth LlcUniversity Of California San FranciscoRevue Juridique Des Etudiants Et Etudiantes De L'Universite Laval Inc +[4] 
Active IndicationsOestrogen deficiency symptomsVasomotor symptomMenopausal symptoms +[8] 
Inactive IndicationsHot FlashesAtrophic VaginitisEndometrial Hyperplasia +[6] 

Other Information

ATC CodeG03CC07
Related LinksKEGG